Autres langues Strides Pharma Science Limited Bombay S.E.

Actions

STAR

INE939A01011

Produits pharmaceutiques

Marché Fermé - Bombay S.E. 12:03:02 11/09/2026			Varia. 5j.	Varia. 1 janv.
1 186,10 ^INR	-2,59%		+12,60%	+31,45%

13/08	Vintage Classic Limited et Ascent Capital Advisors India Private Limited acquièrent une participation de 65,05 % dans Pivot Path Private Limited auprès de Strides Pharma Science Limited (NSEI:STAR) pour 1,0 milliard d'INR.	CI
31/07	Transcript : Strides Pharma Science Limited, Q1 2027 Earnings Call, Jul 31, 2026

Autres langues

19/08	Strides Pharma Science Limited Receives USFDA Establishment Inspection Report for Bengaluru Facility
13/08	Vintage Classic Limited and Ascent Capital Advisors India Private Limited acquired 65.05% stake in Pivot Path Private Limited from Strides Pharma Science Limited for INR 1.0 billion.
31/07	Strides Pharma Science Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
27/06	Vintage Classic Limited and Ascent Capital Advisors India Private Limited agreed to acquire 65.05% stake in Pivot Path Private Limited from Strides Pharma Science Limited for INR 1.0 billion.
18/05	Strides Pharma Science Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
18/05	Strides Pharma Science Limited Announces Management Changes Effective June 1, 2026
18/05	Strides Pharma Science Limited Recommends Final Dividend for Financial Year Ended March 31, 2026
18/05	Strides Pharma Science March-quarter consol net profit 1.27 billion rupees
18/03	Strides Pharma Science Unit to Acquire, In-License Sandoz Portfolio in Africa; Shares Jump 4%
17/03	India's Strides Pharma expands Africa footprint with $12mn Sandoz generics deal
17/03	Strides Pharma Science enters agreement to buy, in-license generic brands from Sandoz in Africa
17/02	Strides Pharma Arm Acquires Remaining 50% Stake in Neviton
05/02	Strides Pharma Science Gets Closure Report from US FDA after New York Unit Inspection
05/02	Strides Pharma Science says unit gets USFDA EIR report for formulations facility at Chestnut Ridge
30/01	Strides Pharma Science Consolidated Profit Jumps in Fiscal Q3; Shares Up 6%
30/01	Strides Pharma Science Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
30/01	Strides Pharma Science Ltd Dec-quarter consol net profit 2.02 billion rupees
24/12	Strides Pharma Science says completion of US-FDA inspection at co's USA facility
03/12	Strides Pharma Science's Chief Human Resources Officer to Resign
03/12	Strides Pharma Science Limited Announces Executive Changes
31/10/25	Strides Pharma Science Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
31/10/25	Strides Pharma Science Sept-quarter consol net profit 1.28 billion rupees
27/10/25	Strides Pharma Science : Intimation on Board Meeting scheduled for Oct 31, 2025
08/09/25	Strides Pharma Science partners with Kenox to expand nasal spray portfolio
26/08/25	Strides Pharma Science Deregisters Non-Operating South Africa Unit